Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Onkologie|December 5, 2012
Biliary tract cancer: a survey regarding the current oncological daily care practice in GermanyMarianne Sinn, Sven Bischoff, Oliver Nehls, et al.
Oncology Research and Treatment|November 25, 2015
Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus GemcitabineArndt Vogel, Frank Kullmann, Volker Kunzmann, et al.
Haematologica|July 2, 2011
Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 casesRalf Trappe, Heiner Zimmermann, Susanne Fink, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 26, 2009
Thrombin activity throughout the acute phase of acute ST-elevation myocardial infarction and the relation to outcomeNatalie-Viviane Ulrich-Möckel, Matthias Riehle, Jörn Vollert, et al.
Wiener Medizinische Wochenschrift (1946)|June 9, 2004
[Standards and perspectives in locoregional hyperthermia]Bert Hildebrandt, Beate Rau, Johanna Gellermann, et al.
Pancreas|December 10, 2015
Second-Line Treatment in Pancreatic Cancer Patients: Who Profits?--Results From the CONKO Study GroupMarianne Sinn, Louise Dälken, Jana Käthe Striefler, et al.
BMC Cancer|December 6, 2008
Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)Hanno Riess, Uwe Pelzer, Andreas Hilbig, et al.
Journal of Surgical Oncology|July 21, 2015
Prognostic significance of DNA cytometry for adjuvant therapy response in pancreatic cancerFritz Klein, Marcus Bahra, Anja Schirmeier, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2018
Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospective analysisUwe Pelzer, Lilianna Wislocka, Anja Jühling, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2011
First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study groupUwe Pelzer, Dirk Arnold, Peter Reitzig, et al.
Pageof 15